Featured Research

from universities, journals, and other organizations

Scientists find mechanism that leads to drug resistance in bacteria causing melioidosis

Date:
October 4, 2011
Source:
Wellcome Trust
Summary:
Researchers have identified a novel mechanism whereby the organism Burkholderia pseudomallei -- the cause of melioidosis, a neglected tropical infectious disease -- develops resistance to ceftazidime, the standard antibiotic treatment. The change also makes the drug-resistant bacterium difficult to detect.

Researchers in South East Asia have identified a novel mechanism whereby the organism Burkholderia pseudomallei -- the cause of melioidosis, a neglected tropical infectious disease -- develops resistance to ceftazidime, the standard antibiotic treatment. The change also makes the drug-resistant bacterium difficult to detect.

Related Articles


B. pseudomallei is found in water and soil predominately in tropical climates and especially in South East Asia. It can infect both humans and animals and causes melioidosis. The disease often occurs in people who have underlying diseases such as type 2 diabetes or renal disease. Symptoms range from relatively mild to severe, and the mortality rate in Asia is as high as four out of ten cases.

Infection is treated using ceftazidime, a third-generation cephalosporin β-lactam antibiotic, which is a derivative of penicillin. This drug is often required for several weeks, during which the bacteria may develop resistance to it. Now, in a paper published in the Proceedings of the National Academy of Science, researchers from the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme in Bangkok, Thailand, and the University of Cambridge, in collaboration with Colorado State University and Genome Institute of Singapore, have identified how the bacteria develop this resistance.

By comparing the genetic make-up of isolates taken from six patients that had become resistant to ceftazidime against their original infecting ceftazidime-susceptible strain, the researchers found a common, large-scale genomic loss involving at least 49 genes that is thought to arise spontaneously as the bacteria replicate and mutate. The researchers were able to demonstrate that a specific gene within this region was the cause of the drug resistance. This gene provides the genetic 'code' to create a protein that is important to bacterial cell division and that is normally the target for ceftazidime.

The researchers also found that these mutated forms of B. pseudomallei would not grow in common laboratory cultures, including bottles that are normally used to culture blood from people with bacterial infections, as well as the routine culture media used in the diagnostic laboratory. This makes the detection of the drug-resistant forms very difficult. Consequently, patients carrying this strain could continue to be treated with drugs that have become ineffective.

Professor Sharon Peacock, the team lead and a professor of clinical microbiology at both Mahidol University and the University of Cambridge, said: "Clinical treatment failure occurs in as many as one in six patients receiving ceftazidime for melioidosis. The mechanism described here represents the first explanation for failure of ceftazidime therapy, may be a frequent but undetected event, and provides us with an opportunity to seek ways to increase detection of these variants."

Dr Narisara Chantratita led the work undertaken at Mahidol University. She was awarded a Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine in 2009. This scheme provides support to researchers from low- and middle-income countries.

Combating infectious diseases is one the strategic priorities of the Wellcome Trust. Much of this work is carried out at a local level in regions where disease is endemic. This includes several major overseas programmes, including the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme.

Commenting on the research, Professor Danny Altmann, Head of Pathogens, Immunology and Population Health at the Wellcome Trust, said: "The development of drug resistance is a major concern for doctors, particularly in low and middle income countries. This study helps us understand how resistance can occur and can hopefully lead to better detection and treatment of drug-resistant forms of melioidosis, a life-threatening tropical disease."


Story Source:

The above story is based on materials provided by Wellcome Trust. Note: Materials may be edited for content and length.


Cite This Page:

Wellcome Trust. "Scientists find mechanism that leads to drug resistance in bacteria causing melioidosis." ScienceDaily. ScienceDaily, 4 October 2011. <www.sciencedaily.com/releases/2011/10/111003151830.htm>.
Wellcome Trust. (2011, October 4). Scientists find mechanism that leads to drug resistance in bacteria causing melioidosis. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2011/10/111003151830.htm
Wellcome Trust. "Scientists find mechanism that leads to drug resistance in bacteria causing melioidosis." ScienceDaily. www.sciencedaily.com/releases/2011/10/111003151830.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
Toxin-Packed Stem Cells Used To Kill Cancer

Toxin-Packed Stem Cells Used To Kill Cancer

Newsy (Oct. 25, 2014) — A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed. Video provided by Newsy
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins